Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns
Aurora Cannabis (NYSE: ACB)
has been put between what could be considered as a rock and a hard place. The company, recently favored by Cowen & Co analysts, immediately faced decreases in value that similar cannabis corporations within the cannabis sector felt today. Cannabis stocks fell across the board after FDA Chief Dr. Scott Gottlieb announced his resignation.
Despite the news: we would recommend purchasing shares in ACB at this time.
Vivien Azer, established analyst at Cowen & Co, placed an Outperform rating on Aurora Cannabis with a price point target of $10.50 or C$14. Cowen analysts touted the company’s ability to capture 20% of the Canadian cannabis market share and its large cultivation footprint of 575,000kg.
{{cta(’69f63bd3-e695-415f-8c83-b207c29317a6′)}}
“While establishing 20% market share has been an early success story in Canadian adult use cannabis, the company is uniquely positioned to drive leadership in both share and profitability,” said Azer.
ACB shares peaked at $8.42 today, before it tumbled, and is currently at a 9.29% increase after market close on Monday of this week. After the Cowen announcement, the value of ACB rose more than 12% on Tuesday, and continued for another 2.59% until it hit the $8.42 peak in value on Wednesday.
Curious about other cannabis stocks with massive growth potential? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.
Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns
About Cannin Investment Group: Your Pot Stocks Experts
Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in pot stocks? No! This is the perfect time to invest.
Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.
Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?
Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best pot stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Buy
Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns
